株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

敗血症診断:アッセイ技術別の動向・予測 (2020-2024年)

Sepsis Diagnostics Global Markets by Assay Technology with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024

発行 Howe Sound Research 商品コード 928146
出版日 ページ情報 英文 248 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.72円で換算しております。
敗血症診断:アッセイ技術別の動向・予測 (2020-2024年) Sepsis Diagnostics Global Markets by Assay Technology with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024
出版日: 2020年03月08日 ページ情報: 英文 248 Pages
概要

敗血症には確定的な診断法がなく、年間の死亡者は3000万名を超えています。過去10年で台頭したゲノムおよび分子診断ツールを用いた診断法の確立に向け、競合が始まっています。

当レポートでは、敗血症診断の市場を調査し、敗血症の概要、市場構成・参入事業者、市場成長への主な影響因子の分析、企業間の各種展開、技術開発の動向、主要企業のプロファイル、アッセイタイプ・製品タイプ・主要国別の市場規模の予測などをまとめています。

第1章 イントロダクション・市場の定義

第2章 敗血症:現況

  • 敗血症とは
  • 診断
    • 感染症同定
    • バイオマーカー
    • 鑑別診断
  • 敗血症の原因
  • 有病率

第3章 産業概要

  • 参入事業者・機関

第4章 市場動向

  • 成長推進因子
  • 成長抑制因子
  • 診断技術の開発

第5章 敗血症診断:近年の展開

  • NGS技術が敗血症の迅速かつ正確な診断を提供
  • ポータブル機器による迅速な診断
  • Ontera・QuantuMDx:敗血症診断で連携
  • 血液検査による敗血症の重症度の正確な予測
  • HHS:Cytovale迅速検査の開発を進める
  • Mologic:マルチマーカーを使用した敗血症検査を開発
  • Abionic:5分間での敗血症診断の実証成果を示す
  • T2 Biosystems:迅速診断技術の新たなデータ・更新
  • 敗血症:4つのサブタイプに適合することが判明
  • GenMark Diagnostics:血液パネルでFDAクリアランスを取得
  • Novacyt・Immunexpress:敗血症アッセイ開発での提携を延長、など

第6章 主要企業のプロファイル

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biocartis
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • Cube Dx
  • Curetis N.V. / Curetis GmbH
  • Cytovale
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc

第7章 敗血症診断市場:国別

第8章 敗血症診断市場:各種タイプ別

  • 診断タイプ・アッセイタイプ別
  • 微生物アッセイ
  • 症候群PoCパネル
  • その他の感染症
  • バイオマーカー分子診断
  • バイオマーカー (その他)

第9章 敗血症診断市場:製品タイプ別

  • 機器
  • 試薬
  • ソフトウェア&サービス

付録

図表

Table of Tables

  • Table 1 Lab Spending 2014 to 2024
  • Table 2 sepsis biomarkers - Established and potential
  • Table 3 Market Players by Type
  • Table 4 Five Factors Driving Growth
  • Table 5 Three Factors Limiting Growth
  • TABLE 6 - GLOBAL SEPSIS DIAGNOSTICS MARKET BY COUNTRY/REGION
  • TABLE 7 GLOBAL MARKET BY ASSAY TYPE
  • TABLE 8 SEPSIS DIAGNOSTIC MICROBIOLOGY BY COUNTRY
  • TABLE 9 SEPSIS DIAGNOSTIC SYNDROMIC POC PANEL BY COUNTRY
  • TABLE 10 SEPSIS DIAGNOSTIC OTHER ID BY COUNTRY
  • TABLE 11 SEPSIS DIAGNOSTIC BIOMARKER MDX BY COUNTRY
  • TABLE 12 SEPSIS DIAGNOSTIC BIOMARKER OTHER BY COUNTRY
  • TABLE 13 GLOBAL MARKET BY PRODUCT TYPE
  • TABLE 14 SEPSIS DIAGNOSTIC INSTRUMENTS BY COUNTRY
  • TABLE 15 SEPSIS DIAGNOSTIC REAGENTS BY COUNTRY
  • TABLE 16 SEPSIS DIAGNOSTIC SW & SERV BY COUNTRY
  • Table 17 2019 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Sepsis Survival graph
  • Figure 2 Percentage of Sepsis Patients with Comorbidity
  • Figure 3 Clinical Lab Spending 2014 to 2024
  • Figure 4 Sepsis Clinical Progression
  • Figure 5 Deaths From Drug Resistant Infections 2050
  • Figure 6 Aggregate Age of World Population
  • Figure 7 Growth in Health Care Spending Developing World
  • Figure 8 Comparing The New Diagnostics and Traditional Testing
  • Figure 9 Growth rates of Sepsis Diagnostics
  • Figure 10 Global Market Density Chart
  • Figure 11 Sepsis Diagnostics Market by Type - 2019 vs. 2024
  • FIGURE 12 SEPSIS DIAGNOSTICS MARKET 2019
  • FIGURE 13 SEPSIS DIAGNOSTICS MARKET 2024
  • FIGURE 14 TYPE SHARE BY YEAR
  • FIGURE 15 SEPSIS DIAGNOSTIC MICROBIOLOGY GROWTH
  • FIGURE 16 SEPSIS DIAGNOSTICS SYNDROMIC POC PANEL GROWTH
  • FIGURE 17 SEPSIS DIAGNOSTIC OTHER INFECTIOUS DISEASE GROWTH
  • FIGURE 18 SEPSIS DIAGNOSTIC MOLECULAR DIAGNOSTICS GROWTH
  • FIGURE 19 SEPSIS DIAGNOSTIC BIOMARKER OTHER GROWTH
  • Figure 20 Sepsis Diagnostics Market by Product Type - 2019 vs. 2024
  • FIGURE 21 SEPSIS DIAGNOSTICS MARKET BY PRODUCT TYPE BASE YEAR
  • FIGURE 22 SEPSIS DIAGNOSTICS MARKET BY PRODUCT TYPE FINAL YEAR
  • FIGURE 23 PRODUCT TYPE SHARE BY YEAR
  • FIGURE 24 SEPSIS DIAGNOSTIC INSTRUMENTS GROWTH
  • FIGURE 25 SEPSIS DIAGNOSTICS HBA1C GROWTH
  • FIGURE 26 SEPSIS DIAGNOSTIC SE & SERVICES GROWTH
目次

OVERVIEW:

Sepsis is killing over 30 million people a year with no definitive diagnostic in hand. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium in the market. Understand what is driving this huge global diagnostic market and where the opportunity lies.

Our facts and support = Your success.

The report forecasts the market size out to 2024. Growth is coming from the basic factors but technology and education are creating the awareness needed to rapidly expand the diagnostic market. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnositic and the Genomics Revolution are merging to create new diagnostic opportunities.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

  • i. Market Guides
    • iA. Situation Analysis
    • iB. Guide for Executives and Marketing Staff
    • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 An Overview of Sepsis Diagnostics
    • 1.1.1 Sepsis the medical emergency
    • 1.1.2 Sepsis Diagnosis and Comorbidity
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
    • 1.3.4 Microbiology
    • 1.3.5 Other Infectious Disease
    • 1.3.6 Syndromic PoC
    • 1.3.7 Biomarkers Molecular Diagnostics
    • 1.3.8 Biomarkers Other
    • 1.3.9 Limitations
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Sepsis - Current Science

  • 2.1 What is Sepsis?
    • 2.1.1 Organ Damage
    • 2.1.2 Neonatal sepsis
    • 2.1.3 Prognosis
  • 2.2 Diagnosis
    • 2.2.1 Infection Identification
    • 2.2.2 Biomarkers
    • 2.2.3 Differential diagnosis
  • 2.3 Causes of Sepsis
    • 2.3.1 Sepsis Progression
  • 2.4 Prevalence

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Pharmaceutical/Reagent Supplier
    • 3.1.4 Independent Testing Lab
    • 3.1.6 Public National/regional lab
    • 3.1.7 Hospital lab
    • 3.1.8 Physician Lab
    • 3.1.9 Audit Body
    • 3.1.10 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Increasing Prevalence
    • 4.1.2 Antimicrobial Resistance
    • 4.1.3 Increasing Diagnosis
    • 4.1.4 Multiplex Diagnostics Impacts
    • 4.1.5 The Aging World
    • 4.1.6 Developing World Health Care Spending
  • 4.2 Factors Limiting Growth
    • 4.2.1 The Cost Curve Shrinks the Market
    • 4.2.2 The Diagnostics Dillemma
    • 4.2.3 Adoption Lag and Cost Control
  • 4.3 Diagnostic Technology Development
    • 4.3.1 The Multiplex Opportunity
    • 4.3.2 Shifting Role of Physicians in Diagnosis
    • 4.3.3 Diagnostics Moves Out of the Lab
    • 4.3.4 Biomarkers and Algorithms
    • 4.3.5 Rapid Testing Changing Medical Practice
    • 4.3.6 Genome Role and Big Data
    • 4.3.6 The Next Five Years

5. Sepsis Diagnostics - Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • NGS technique offers quick, accurate diagnosis of sepsis
      • Portable device diagnoses sepsis faster
      • Ontera and QuantuMDx Collaborate to Advance Sepsis Diagnosis
      • Blood Test Accurately Predicts Sepsis Severity
      • Sepsis diagnostics: HHS to advance development of Cytovale rapid test
      • Mologic Developing Sepsis Test Using Multimarker
      • Abionic: Study Demonstrates Diagnosis of Sepsis in 5 Minutes
      • T2 Biosystems Introduces New Data and Updates for Rapid Diagnostic Technology
      • Sepsis found to fit into 4 subtypes
      • GenMark Diagnostics Receives FDA Clearance for Blood Panel
      • Novacyt, Immunexpress Extend Sepsis Assay Development Partnership
      • New Test Could Diagnose Sepsis Faster
      • Immunexpress Wins $745K HHS Contract for Rapid Sepsis Assay
      • Curetis' Unyvero Application Cartridges Receive Regulatory Approvals
      • Luminex to Pay $75M for MilliporeSigma's Flow Cytometry Research Portfolio
      • Experimental 2.5-minute Sepsis Test Discovered
      • sphingotec raises €20 million
      • SeLux Diagnostics Announces Sepsi U.S. HHS/BARDA Research Funding
      • Roche PCT assay cleared as tool in fight against Sepsis
      • GeneFluidics selected as finalist for AMR Challenge
      • BioDirection, Inc. Announces System to Diagnose and Monitor Sepsis
      • sphingotec Adding Advanced POC Testing Platform
      • Rapid Detection Using DNAe's LiDia® Bloodstream Infection Technology
      • Septec Team Working on 15 Minute Sepsis Diagnosis
      • Abionic Announces Rapid Sepsis PoC Diagnostic

6. Profiles of Key Companies

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biocartis
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • Cube Dx
  • Curetis N.V. / Curetis GmbH
  • Cytovale
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc

7. Sepsis Diagnostic Markets

  • 7.1 Sepsis Diagnostics - Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country

8. Global Sepsis Diagnostics Markets - By Assay Type

  • 8.1 Global Market by Diagnostic Type - Overview
    • 8.1.1 Table - Global Market by Diagnostic Type
    • 8.1.2 Chart - Global Market by Assay Type
    • 8.1.3 Chart - Global Market by Type - 2019
    • 8.1.4 Chart - Global Market by Type -2024
    • 8.1.4 Chart - Global Market by Type - Share by Year
  • 8.2 Sepsis Diagnostic - Microbiology
    • 8.2.1 Table Sepsis Diagnostic Microbiology - by Country
    • 8.2.2 Chart - Sepsis Diagnostic Microbiology Growth
  • 8.3 Sepsis Diagnostic - Syndromic PoC Panel
    • 8.3.1 Table Sepsis Diagnostic Syndromic PoC Panel - by Country
    • 8.3.2 Chart - Sepsis Diagnostic Syndromic PoC Panel Growth
  • 8.4 Sepsis Diagnostic - Other Infectious Disease
    • 8.4.1 Table Sepsis Diagnostic Other ID - by Country
    • 8.4.2 Chart - Sepsis Diagnostic - Other Infectious Disease Growth
  • 8.5 Sepsis Diagnostic - Biomarker Molecular Diagnostic
    • 8.5.1 Table Sepsis Diagnostic Biomarker MDx - by Country
    • 8.5.2 Chart - Sepsis Diagnostic - Biomarker MDx Growth
  • 8.6 Sepsis Diagnostic - Biomarker Other
    • 8.6.1 Table Sepsis Diagnostic Biomarker Other - by Country
    • 8.6.2 Chart - Sepsis Diagnostic - Biomarker Other Growth

9. Global Sepsis Diagnostics Markets - By Product Type

  • 9.1 Global Market by Product Type - Overview
    • 9.1.1 Table - Global Market by Product Type
    • 9.1.2 Chart - Global Market by Product Type - 2019/2024 Comparison
    • 9.1.3 Chart - Global Market by Product Type - Base Year
    • 9.1.4 Chart - Global Market by Product Type - Final Year
    • 9.1.4 Chart - Global Market by Product Type - Share by Year
  • 9.2 Sepsis Diagnostic - Instruments
    • 9.2.1 Table Sepsis Diagnostic Instruments - by Country
    • 9.2.2 Chart - Sepsis Diagnostic Instruments Growth
  • 9.3 Sepsis Diagnostic - Reagents
    • 9.3.1 Table Sepsis Diagnostic Reagents - by Country
    • 9.3.2 Chart - Sepsis Diagnostic Reagents Growth
  • 9.4 Sepsis Diagnostic - Software & Service
    • 9.4.1 Table Sepsis Diagnostic SW & Service - by Country
    • 9.4.2 Chart - Sepsis Diagnostic - SW & Services Growth

Appendices

  • I. United States Medicare System: 2019 Clinical Laboratory Fees Schedule - National Limit and Midpoint